Cargando…
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269703/ https://www.ncbi.nlm.nih.gov/pubmed/32273254 http://dx.doi.org/10.1016/j.sapharm.2020.03.020 |
| _version_ | 1783541804770000896 |
|---|---|
| author | Brown, Joshua D. |
| author_facet | Brown, Joshua D. |
| author_sort | Brown, Joshua D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7269703 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72697032020-06-05 Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic Brown, Joshua D. Res Social Adm Pharm Article Elsevier Inc. 2021-01 2020-03-31 /pmc/articles/PMC7269703/ /pubmed/32273254 http://dx.doi.org/10.1016/j.sapharm.2020.03.020 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Brown, Joshua D. Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title | Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title_full | Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title_fullStr | Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title_full_unstemmed | Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title_short | Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic |
| title_sort | cannabidiol as prophylaxis for sars-cov-2 and covid-19? unfounded claims versus potential risks of medications during the pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269703/ https://www.ncbi.nlm.nih.gov/pubmed/32273254 http://dx.doi.org/10.1016/j.sapharm.2020.03.020 |
| work_keys_str_mv | AT brownjoshuad cannabidiolasprophylaxisforsarscov2andcovid19unfoundedclaimsversuspotentialrisksofmedicationsduringthepandemic |